Clinical Trial Update: Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar [Phase 4]

View source ↗

Summary

Phase 4 trial update on Acthar for treatment of chronic antibody-mediated rejection in kidney transplant patients with transplant glomerulopathy; study terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transplant Glomerulopathy

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Transplant Glomerulopathy | Phase 4 | Status: TERMINATED | Results posted: 2022-10-06